contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Magnasense operates in the pharmaceutical industry. The company specializes in the research and development of various drug candidates. The product portfolio is broad and mainly includes drugs for the treatment of multiple sclerosis. In addition to the main business, associated ancillary services are offered. The business is run in collaboration with other pharmaceutical actors, where the largest presence is found in the Nordic region.

Magnasense

Magnasense AB, a leading innovator in diagnostic technologies, today announces the filing of a patent application covering an advanced detection system designed to improve the sensitivity and...

<div class="mfn-preamble"><p><strong>Magnasense AB, a leading innovator in diagnostic technologies, today announces the filing of a patent application covering an advanced detection system designed to improve the sensitivity and accuracy of magnetic test strips using superparamagnetic nanoparticles.</strong></p></div><div class="mfn-body"><p>The patent-pending system introduces a novel method for detecting superparamagnetic nanoparticles in magnetic test strips. It incorporates a magnetic field generator activated by an excitation signal, paired with a magnetic field sensor that measures shifts in magnetic field strength. When specific biomarkers are present in a sample, the sensor detects these changes, allowing for accurate detection and measurement of target analytes.</p><p>"Our technology marks a significant advancement in point-of-care diagnostics," said Marco Witteveen, CEO of Magnasense. "The enhanced sensitivity and precision of our system will enable earlier, more reliable detection of biomarkers across a wide range of conditions and sample types. This innovation has the potential to reduce cost per test and redefine how diagnostic testing is conducted."</p><p>The patent-pending system introduces a novel method for detecting superparamagnetic nanoparticles in magnetic test strips. It incorporates a magnetic field generator activated by an excitation signal, paired with a magnetic field sensor that measures shifts in magnetic field strength. When specific biomarkers are present in a sample, the sensor detects these changes, allowing for accurate detection and measurement of target analytes. The application filling number is 63/693,525.</p><p>Ideally suited for point-of-care applications, the technology facilitates rapid, dependable diagnostics without the need for complex lab infrastructure. Its versatility allows it to be applied across various disease states, providing healthcare professionals with the tools to make quicker, better-informed decisions. This breakthrough promises to have wide-reaching applications in healthcare, benefiting both medical practitioners and patients through improved diagnostic accuracy.</p></div><div class="mfn-footer mfn-contacts mfn-e503b60338ed"><p><strong class="mfn-heading-1">For additional information, please contact:</strong><br>Marco Witteveen, CEO, Magnasense AB<br>Email: <a rel="noopener" href="mailto:ir@aegirbio.com">ir@magnasense.com</a><br>The Company’s Certified Adviser is Eminova Fondkommission AB | adviser@eminova.se</p></div><div class="mfn-footer mfn-about mfn-8c31e8f3e677"><p><strong class="mfn-heading-1">About Magnasense AB</strong><br>Magnasense is a Swedish diagnostics company founded in 2019 to offer tests to monitor and optimize the dosage of biological drugs via its unique patented technology platform. In June 2020, Magnasense was listed on the Nasdaq First North Growth Market. The company's ambition is, in addition to bringing innovative diagnostic technology to the market, to make diagnostics more accessible, easier to use and to provide accurate and easily transferable results. For more information, see Magnasense's website www.magnasense.com.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/b855789d-636e-4d1a-8b57-5996447e896c/magnasense-files-a-patent-application.pdf" class="mfn-generated mfn-primary">Magnasense files a patent application</a></p></div>

Magnasense files a patent application

Return on capital (ROE, ROI, ROIC, RONIC)

What does negative working capital mean and why is it a good thing?

Drug development investment: Value creation through M&As and licensing agreements

Income statement

Amazon and Costco in Sweden: A looming threat that Nordic retailers ignore at their peril

Stay up to date with our newsletter